Treatment of autoimmune patients.
Gergely
P
P
2nd Department of Medicine, Semmelweis University, Budapest.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000974:Antibodies, Antinuclear / Q000032:analysis; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000628:therapy*; D002738:Chloroquine / Q000627:therapeutic use; D003176:Complement C3 / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D016572:Cyclosporine / Q000627:therapeutic use; D005973:Glutamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007159:Immunologic Tests; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000188:drug therapy; D010281:Parathyroid Hormone / Q000627:therapeutic use; D013654:Taurine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013951:Thymus Hormones / Q000627:therapeutic use; D014801:Vitamin A / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000974:Antibodies, Antinuclear; D000970:Antineoplastic Agents; D003176:Complement C3; D003181:Complement C4; D010281:Parathyroid Hormone; D013951:Thymus Hormones; D005973:Glutamine; D014801:Vitamin A; D013654:Taurine; D016572:Cyclosporine; D002738:Chloroquine; C020903:glutaurine